The FDA is asking for a 29% increase in funds to monitor the safety of drugs already on the market. The $87.4 million hike in fees paid by the industry would include funds for better checks of drug ads. Critics said the request is too modest but is a step in the right direction. Read the FDA release.
Published in Brief: